Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Jun 12, 2020
Date Accepted: Aug 18, 2020

The final, peer-reviewed published version of this preprint can be found here:

Influenza Screening via Deep Learning Using a Combination of Epidemiological and Patient-Generated Health Data: Development and Validation Study

Choo H, Kim M, Shin J, Shin SY

Influenza Screening via Deep Learning Using a Combination of Epidemiological and Patient-Generated Health Data: Development and Validation Study

J Med Internet Res 2020;22(10):e21369

DOI: 10.2196/21369

PMID: 33118941

PMCID: 7661232

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Influenza screening via deep learning using a combination of epidemiological and patient-generated health data

  • Hyunwoo Choo; 
  • Myeongchan Kim; 
  • Jaewon Shin; 
  • Soo-Yong Shin

ABSTRACT

Background:

Screening for influenza in primary care is challenging due to the low sensitivity of rapid antigen tests and a lack of proper screening tests.

Objective:

We developed a machine learning-based screening tool using patient-generated health data (PGHD) obtained from a mobile application (mHealth app).

Methods:

We trained a deep learning model based on GRU to identify influenza based on the PGHD, using each patient’s fever pattern, drug administration records, app-based surveillance calculated from the number of weekly influenza users reported through the app, and meteorological data. We defined a single episode as the set of consecutive days containing the day the user was diagnosed with influenza or other diseases. Any record a user entered after 24 hours from his or her last record was considered as belong to a new episode. Each episode must contain user’s age, gender, weight, and at least one body temperature records. The total number of our dataset was 6,657, of which 3,189 were diagnosed with influenza.

Results:

We achieved reliable performance with an accuracy of 82%, sensitivity of 84%, and specificity of 80% in test set. To evaluate the effect of each input variable, we conducted two experiments. One is removing a variable one by one and observe the change of performance, Another is adding the variable one by one to the base features and observe the change of performance. As a result, app-based surveillance turned out to be most influential variable. We also looked at the correlation between the duration of input data and performance. The Spearman’s rank correlation coefficient was 0.09162, which means the association was not significant.

Conclusions:

These findings suggest that PGHD from a mHealth app could be a complementary tool for influenza screening. Especially, it could be good screening method for infectious disease. In addition, PGHD, along with traditional clinical data, could be used to help improve health conditions.


 Citation

Please cite as:

Choo H, Kim M, Shin J, Shin SY

Influenza Screening via Deep Learning Using a Combination of Epidemiological and Patient-Generated Health Data: Development and Validation Study

J Med Internet Res 2020;22(10):e21369

DOI: 10.2196/21369

PMID: 33118941

PMCID: 7661232

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.